Education
About Us
Working with TipRanks
Follow Us
Instil Bio, Inc. (TIL)
NASDAQ:TIL
| Dec 24 | Dec 23 | Mar 23 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 138.00K |
| Gross Profit | $ 0.00 | $ 0.00 | $ -5.99M | $ 0.00 | $ 138.00K |
| Operating Income | $ -73.54M | $ -159.17M | $ -206.17M | $ -155.56M | $ -33.64M |
| EBITDA | $ -62.53M | $ -147.12M | $ -217.38M | $ -152.51M | $ -33.39M |
| Net Income | $ -74.14M | $ -156.09M | $ -223.18M | $ -156.79M | $ -37.74M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 113.31M | $ 150.36M | $ 260.92M | $ 454.10M | $ 241.71M |
| Total Assets | $ 263.57M | $ 325.63M | $ 482.13M | $ 609.98M | $ 319.01M |
| Total Debt | $ 86.89M | $ 86.05M | $ 79.90M | $ 0.00 | $ 0.00 |
| Net Debt | $ 78.08M | $ 76.86M | $ 36.19M | $ -37.59M | $ -241.71M |
| Total Liabilities | $ 94.13M | $ 99.80M | $ 118.52M | $ 54.78M | $ 26.64M |
| Stockholders' Equity | $ 169.44M | $ 225.83M | $ 363.61M | $ 555.20M | $ 292.37M |
| Cash Flow | |||||
| Free Cash Flow | $ -65.70M | $ -102.69M | $ -264.75M | $ -179.97M | $ -80.43M |
| Operating Cash Flow | $ -55.70M | $ -82.03M | $ -180.16M | $ -122.14M | $ -29.62M |
| Investing Cash Flow | $ 53.97M | $ 41.13M | $ 114.54M | $ -474.40M | $ -51.12M |
| Financing Cash Flow | $ 1.75M | $ 8.08M | $ 71.89M | $ 393.16M | $ 313.05M |
Instil Bio Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.